Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Receivables Refunds (2019 - 2021)

Avanos Medical's Receivables Refunds history spans 3 years, with the latest figure at $13.0 million for Q4 2021.

  • On a quarterly basis, Receivables Refunds fell 78.08% to $13.0 million in Q4 2021 year-over-year; TTM through Dec 2021 was $13.0 million, a 78.08% decrease, with the full-year FY2021 number at $13.0 million, down 78.08% from a year prior.
  • Receivables Refunds hit $13.0 million in Q4 2021 for Avanos Medical, up from $11.6 million in the prior quarter.
  • Over the last five years, Receivables Refunds for AVNS hit a ceiling of $59.3 million in Q4 2020 and a floor of $11.4 million in Q4 2019.
  • Historically, Receivables Refunds has averaged $35.4 million across 3 years, with a median of $35.7 million in 2021.
  • Biggest five-year swings in Receivables Refunds: skyrocketed 420.18% in 2020 and later plummeted 78.08% in 2021.
  • Tracing AVNS's Receivables Refunds over 3 years: stood at $11.4 million in 2019, then skyrocketed by 420.18% to $59.3 million in 2020, then plummeted by 78.08% to $13.0 million in 2021.
  • Business Quant data shows Receivables Refunds for AVNS at $13.0 million in Q4 2021, $11.6 million in Q3 2021, and $58.4 million in Q2 2021.